SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-16-020730
Filing Date
2016-11-03
Accepted
2016-11-03 16:03:21
Documents
50
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q adms10q9302016.htm 10-Q 933154
2 EXHIBIT 10.1 amdsq310q2016ex101.htm EX-10.1 73645
3 EXHIBIT 31.1 admsq310q2016ex311.htm EX-31.1 14146
4 EXHIBIT 31.2 admsq310q2016ex312.htm EX-31.2 14167
5 EXHIBIT 32.1 admsq310q2016ex321.htm EX-32.1 9294
12 macpheejohnconsultex1_image1.gif GRAPHIC 2897
  Complete submission text file 0001628280-16-020730.txt   4019366

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT adms-20160930.xml EX-101.INS 702397
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adms-20160930.xsd EX-101.SCH 27240
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adms-20160930_cal.xml EX-101.CAL 45663
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adms-20160930_def.xml EX-101.DEF 135222
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adms-20160930_lab.xml EX-101.LAB 419991
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adms-20160930_pre.xml EX-101.PRE 234148
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36399 | Film No.: 161971516
SIC: 2834 Pharmaceutical Preparations